Selectively inhibit the Bcl-2 protein family members Bcl-2 and Bcl-XL to restore tumor cell apoptosis, thereby killing the tumor, is intended for the treatment of small cell lung cancer and other solid tumors. Here, BCL2L1 is linked to neoplasm.